Residual 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine (18FDOPA) hypermetabolic burden predicted overall survival (OS) for isocitrate dehydrogenase (IDH) wild-type gliomas, regardless of the tumor grade. Here, IDH3A is linked to central nervous system cancer.